Read + Share

Amedeo Smart

Independent Medical Education


Read + Share

Catenacci DVT, Rasco D, Lee J, Rha SY, et al. Phase I Escalation and Expansion Study of Bemarituzumab (FPA144) in Patients With Advanced Solid Tumors and FGFR2b-Selected Gastroesophageal Adenocarcinoma. J Clin Oncol 2020;38:2418-2426.
PMID: 32167861


Free Medical Abstracts
Privacy Policy
Sponsors
Share
About

© Amedeo 1997-2016